Cargando…
Inhaled insulin for controlling blood glucose in patients with diabetes
Diabetes mellitus is a significant worldwide health problem, with the incidence of type 2 diabetes increasing at alarming rates. Insulin resistance and dysregulated blood glucose control are established risk factors for microvascular complications and cardiovascular disease. Despite the recognition...
Autores principales: | Silverman, Bernard L, Barnes, Christopher J, Campaigne, Barbara N, Muchmore, Douglas B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350138/ https://www.ncbi.nlm.nih.gov/pubmed/18200813 |
Ejemplares similares
-
Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
por: Hompesch, Marcus, et al.
Publicado: (2011) -
Combining insulins for optimal blood glucose control in type 1 and 2 diabetes: Focus on insulin glulisine
por: Ulrich, Heather, et al.
Publicado: (2007) -
Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
por: Morrow, Linda, et al.
Publicado: (2013) -
Diabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier function
por: Alves, Marco G., et al.
Publicado: (2013) -
Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes
por: Weinstock, Ruth S., et al.
Publicado: (2022)